A look inside our policy brief urging legislators to consider the impact of health reform on US employers and the 177 million people who receive health coverage from them.

A side-by-side comparison of the leading repeal-and-replace proposals.

According to a new report from the Oliver Wyman Actuarial Practice, MA organizations can expect a drop in revenue next year.

Principal, Oliver Wyman Actuarial Consulting
Principal, Oliver Wyman Actuarial Consulting
Principal, Oliver Wyman Actuarial Consulting

Leaders from Oliver Wyman’s Actuarial Consulting break down how changes to the ACA individual market may play out on a state-by-state basis.

Practice Leader, Oliver Wyman Actuarial Consulting
Partner, Oliver Wyman Actuarial Consulting

Despite changing political winds, value-based initiatives are as relevant as ever. Read new analysis of the ACO market and insight into next, best moves.

Former Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

What does a Trump presidency mean for healthcare organizations? Must-read articles from Oliver Wyman Health.

The election results sent biopharma stock soaring. Breaking down what’s really on tap for biopharma over the next four years.

Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Health & Life Sciences Practice, Oliver Wyman

Two scenarios for how repeal and replace changes might unfold.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Through this series of infographics, learn how payers, providers, and life sciences companies will be impacted by our 45th president.

Partner, Health and Life Sciences, Oliver Wyman

A view into the utilization dynamics of the ACA population.

Insights in your inbox

Subscribe
Load More